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“Multiple Chronic Conditions: A Strategic Frame-
work” is a seminal report and the heart of a US strategic 
initiative, released by the U.S. Department of Health 
and Human Services (HHS) in December 2010, to focus 
the attention and resources of the US government on the 
research, practice, and policy implications of multiple 
chronic conditions (MCCs) [1]. The specifi c purpose 
of the report is “to catalyze change within the context 
of how chronic illnesses are addressed in the United 
States – from an approach focused on individual chronic 
diseases to one that uses a multiple chronic condition 
approach” [1]. The report observes that this process 
represents “a culture change, or paradigm shift, and the 
subsequent implementation of these strategies that will 
provide a foundation for realizing the vision of optimal 
health and quality of life for individuals with multiple 
chronic conditions” [1].
The issue of MCCs is of increasing relevance to the 
international community, as highlighted by a growing 
international literature over the past decade (see [2]). 
Thus, we posit that we can all learn from a conversation 
that builds a truly international perspective, recogniz-
ing that different countries have unique populations and 
health systems, to address the common theme of the 
health of people living with MCCs. The purpose of this 
special issue of the Journal of Comorbidity is to provide an 
international forum for consideration and discussion of 
the MCC report [1], as summarized in an “informed 
overview” prepared by Anand K. Parekh and Richard 
A. Goodman, from the HHS Offi ce of the Assistant Sec-
retary for Health (Parekh and Goodman) and National 
Center for Chronic Disease Prevention and Health 
Promotion, Centers for Disease Control and Preven-
tion (Goodman) [3]. Both Parekh and Goodman were 
instrumental in the development of the MCC report [1]; 
and are, therefore, uniquely qualifi ed to place the report 
in its historical context, recalling the important steps in 
its development. Parekh and Goodman also describe the 
overall goals of the strategic initiative, with a particular 
focus on the goal of facilitating research to fi ll knowl-
edge gaps about MCCs and to establish an evidence base 
of interventions and systems that benefi t individuals 
with MCCs [3]. For this research goal, they highlight 
the four specifi c research objectives. They provide an 
update of current steps by the HHS to enhance: (a) the 
external validity of clinical trials for people with MCCs; 
(b) the epidemiology of MCCs; (c) clinical, community, 
and patient-centered health research; and (d) research on 
disparities in MCCs within populations. Finally, Parekh 
and Goodman conclude by suggesting additional poten-
tial priorities for research in MCCs [3].
An international group of scholars was invited to 
react to the Parekh and Goodman summary of the 
MCC report [3]. Each scholar was asked to address one 
of the four research objectives, and, whenever possi-
ble, to highlight some of the current research, practice, 
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and policy from their home countries. They were also 
encouraged, in particular, to focus on the “how” of 
these four core research topics: what they thought of the 
strategies in the framework; what can be learned from 
related strategies in other countries; the specifi c opera-
tional tasks that will help to accomplish these strategies; 
and fi nally, what the opportunities are to leverage 
resources to advance this agenda through international 
cooperation.
We thank our team of scholars for their excellent con-
tributions. The scholars and their topics are given below.
Martin Fortin and Susan M. Smith – Improving the 
external validity of clinical trials: the case of multiple chronic 
conditions. Fortin and Smith are affi liated with the 
Université de Sherbrooke in Quebec, Canada, and 
the Royal College of Surgeons in Dublin, Ireland, 
respectively. Fortin and Smith agree with Parekh and 
Goodman [3] that individuals with MCCs are often 
excluded from clinical trials, generally considered to 
be the gold standard for the clinical and community-
based research. As such, the generalizability or external 
validity of clinical trials is typically sacrifi ced for the 
internal validity of those trials. This, in turn, severely 
limits the development of an effective evidence base for 
clinical strategies to address MCCs. They emphasize 
that we must not only consider patient factors (the pri-
mary focus of their piece and the MCC report [1]), but 
that system factors are also relevant. Fortin and Smith 
contend that it is necessary to consider alternative and 
complementary designs for trials, alternative sources of 
evidence, including the development and use of sophis-
ticated post-marketing surveillance, treatment fi delity 
studies, and prospective cohort studies. Finally, they 
agree that the innovative use of secondary data should 
be employed.
Francois G. Schellevis – Epidemiology of multiple chronic 
conditions: an international perspective. Schellevis, affi liated 
with the Netherlands Institute for Health Services in 
Utrecht, provides an international context for epidemi-
ological data on MCCs using data from the USA and 
many other countries, and considers the underlying rea-
sons for observed differences. He makes a strong case for 
the utility of focused epidemiological research to better 
inform the development of studies to evaluate the effec-
tiveness of interventions in order to establish an evidence 
base to care for individuals with MCCs. Like other mem-
bers of the international group, he agrees with the MCC 
report about the potential utility of secondary data analy-
sis, especially regarding opportunities for cross-country 
comparisons. Schellevis also argues forcefully for the need 
to further examine the diversity among subpopulations 
within and between countries as a foundation to move 
forward and focus primary attention on intervention 
research.
Jose M. Valderas – Increasing clinical, community, and 
patient-centered health research for preventing and managing 
multimorbidity. Valderas, affi liated with the Universities 
of Exeter and Oxford in the UK, argues that this is the 
broadest of the four research objectives and describes a 
critical need to establish an evidence base to develop a 
range of effective patient-centered programs to improve 
clinical and community care for individuals with MCCs. 
He points out that these types of research are not distinct, 
and are by defi nition inter-related when done well. He 
highlights the focus on determining outcome priorities 
for people with MCCs. All of this work, argues Valderas, 
merits a refi nement of an expanded conceptual model 
for the delivery of healthcare to individuals with MCCs.
Efrat Shadmi – Disparities in multiple chronic conditions 
within populations. Shadmi, from the University of Haifa, 
Israel, strongly agrees with the MCC report in that it is 
important to address the topic of disparities in incidence 
and management of MCCs, and that prevention is a fun-
damental mechanism to consider. While most research 
on MCCs focuses on an aging population, Shadmi con-
tends that research on MCCs, especially among specifi c 
subpopulations, should provide new insights into health 
disparities by race, ethnicity, and socioeconomic status 
among adults in general. She also argues, however, that this 
research depends on the development of more sophisti-
cated measures of MCCs to include acute conditions and 
general symptoms. With a more sophisticated evidence 
base, Shadmi believes that programs and policies can be 
developed to meet the special needs of diverse groups 
within and among populations.
We believe that the articles in this special issue make 
a compelling case that the study of MCCs, while chal-
lenging, will lead to a new generation of clinical and 
community-based programs and policies to enhance 
the health and well-being of a growing and increasingly 
diverse population. The MCC strategic initiative [1], 
as summarized so well by Parekh and Goodman [3], is 
both a report of what we know and what we need to 
know in this area. It includes an examination of work to 
date, including the early studies of Alvin Feinstein and 
his students in the 1970s and 1980s [4,5]. The report, 
which we believe represents the most comprehensive 
and extensive to date, builds on previous programs, ini-
tiatives, and conferences from the USA and elsewhere 
[6–8]. It demonstrates a clear recognition of the promise 
of the fi eld, and provides a specifi c directive for action to 
move research, practice, and policy forward. The reac-
tions to the MCC initiative [1], as expressed by Fortin 
and Smith, Schellevis, Valderas, and Shadmi, indicate 
that this enthusiasm, while tempered by a full appre-
ciation of the diffi culties and challenges in this area, 
is shared by others in countries outside the USA. We 
believe that the MCC initiative is an important fi rst 
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step. In the end, the MCC initiative will be evaluated 
by the extent to which the goals are met. In the near 
term, however, the process and progress of the initia-
tive will be assessed in part by whether the fi nancial and 
funding commitments to MCC research are suffi cient to 
achieve meaningful results that impact the other goals, 
and whether the USA actively collaborates with other 
countries to meet these important research objectives 
and leverage fi nite resources.
Finally, in addition to the topics raised in this rich 
discussion, we recommend three additional areas for 
consideration.
First, attention to living with MCCs must take a life-
course view, as many of the risk factors for MCCs date 
to childhood, and perhaps even gestation, and this view 
may be particularly relevant as we address disparities. 
This includes the risk factors for particular comorbid 
conditions among people with specifi c index conditions. 
Altering this course will take community and environ-
mental strategies as well as those focused on individuals 
or health systems, and the evaluation of such programs 
may stretch well beyond a particular political cycle and 
typical funding mechanisms.
Second, research should focus not only on comorbid-
ity in reference to index conditions, or issues associated 
with particular combinations of conditions, but also on 
an understanding of the generic, underlying commonali-
ties of MCCs in light of the enormous heterogeneity of 
the population with MCCs (see [9,10]). Examples include 
developing and evaluating pragmatic approaches to shared 
decision-making for treatment and care plans, regardless 
of what the specifi c conditions may be, or evaluating and 
refi ning electronic health records in order to enhance 
patient-centered care for people with MCCs [11].
Third, in addition to focusing on the effects of MCCs 
on the health and well-being of specifi c individuals with 
MCCs, attention should also be given to the interplay 
of MCCs on the health and well-being of the caregivers 
and family members of those individuals. Research on 
the social determinants of health underscores that liv-
ing with MCCs is a complex and dynamic process that 
is likely to involve the health status of family members 
(see [12,13]). This involves more than an appreciation of 
“caregiver strain,” as important as that issue is. As just 
one example of the heterogeneous connections between 
family members and their effect on health, an older adult 
caring for a spouse with MCCs may be dealing with his 
or her own set of MCCs; and, together, the issues sur-
rounding their collective MCCs may affect the health 
and well-being of a grandchild for whom they care. A 
better understanding of the social and economic con-
text of MCC, including family health issues of this kind, 
could serve as the foundation for a more comprehensive 
picture of the impact of living with MCCs.
In conclusion, we trust that all healthcare professionals 
involved in the management of patients with MCCs will 
not only fi nd the articles in this special issue interesting 
and informative, but that they will also help to stimu-
late further research, discussion, and guidance on MCCs 
globally.
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